A Clinical Trial of Lasuna Taila Pana and Matrabasti in the Management of Artavakshaya (Oligomenorrhoea)

Comparative Clinical Study to Evaluate the Efficiency of Lasuna Taila Pana and Matrabasti in the Management of Artavakshaya (Oligomenorrhoea) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058305

Enrollment

Registered

2023-10-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Bleeding or spotting less than 2 days. 2. Infrequent menses at interval longer than 35 days or scanty bleeding with minimum 3 days cycle of history of Oligomenorrhoea aur Hypomenorrhea. 4. Irrespective of gravida 5. Both married and unmarried women of age 16 to 45 years.

Exclusion criteria

Exclusion criteria: 1.Patient with systemic disorder like TB, Hypertension, Asthma, Congenital anomalies or allied disease which cause oligomenorrhea or hypomenorrhea. 2.Patient with severe anaemia (HB 4.Women on OCPs or IUCDs.

Design outcomes

Primary

Measure	Time frame
Decrease in symptoms of Artavakshya. 1.Normalise the interval between two cycles. 2.To normalise the amount of blood loss. 3.To normalise the duration of bleeding. 4.Minimise the grade of painTimepoint: 90 Days	—

Secondary

Measure	Time frame
1.USG report to be within normal limits. 2.Serum Prolactin. 3.AMH. 4.TSH T3 T4. 5.HB%Timepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Yanbeni Humtsoe

Government Ayurvedic College Hospital Guwahati

pybeni17@gmail.com8638807437

Outcome results